Home/Filings/4/0001707925-25-000057
4//SEC Filing

White Matthew J 4

Accession 0001707925-25-000057

CIK 0001707925other

Filed

Mar 10, 8:00 PM ET

Accepted

Mar 11, 8:09 PM ET

Size

43.3 KB

Accession

0001707925-25-000057

Insider Transaction Report

Form 4
Period: 2025-03-07
White Matthew J
Chief Financial Officer
Transactions
  • Tax Payment

    Ordinary Shares

    2025-03-10$468.77/sh1,204.841$564,79368,897.23 total
  • Exercise/Conversion

    Ordinary Shares

    2025-03-10+2,60070,102.071 total
  • Tax Payment

    Ordinary Shares

    2025-03-10$468.77/sh3,614.52$1,694,37973,082.71 total
  • Tax Payment

    Ordinary Shares

    2025-03-10$468.77/sh2,216.906$1,039,21975,649.804 total
  • Award

    Performance Share Units (ROC)

    2025-03-10+7,8007,800 total
    Exercise: $0.00Ordinary Shares (7,800 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2025-03-102,6000 total
    Exercise: $0.00Ordinary Shares (2,600 underlying)
  • Award

    Restricted Stock Units

    2025-03-07+2,7282,728 total
    Exercise: $0.00Ordinary Shares (2,728 underlying)
  • Exercise/Conversion

    Ordinary Shares

    2025-03-10+7,80076,697.23 total
  • Exercise/Conversion

    Ordinary Shares

    2025-03-10+4,78477,866.71 total
  • Exercise/Conversion

    Performance Share Units (ROC)

    2025-03-107,8000 total
    Exercise: $0.00Ordinary Shares (7,800 underlying)
  • Award

    Performance Share Units (RTSR)

    2025-03-10+4,7844,784 total
    Exercise: $0.00Ordinary Shares (4,784 underlying)
  • Exercise/Conversion

    Performance Share Units (RTSR)

    2025-03-104,7840 total
    Exercise: $0.00Ordinary Shares (4,784 underlying)
  • Award

    Stock Options (right to buy)

    2025-03-07+19,15619,156 total
    Exercise: $468.77Exp: 2035-03-07Ordinary Shares (19,156 underlying)
Holdings
  • Stock Options (right to buy)

    Exercise: $253.68Exp: 2031-03-08Ordinary Shares (34,320 underlying)
    34,320
  • Stock Options (right to buy)

    Exercise: $465.29Exp: 2034-03-07Ordinary Shares (17,015 underlying)
    17,015
  • Stock Options (right to buy)

    Exercise: $270.99Exp: 2032-03-07Ordinary Shares (22,535 underlying)
    22,535
  • Stock Options (right to buy)

    Exercise: $173.13Exp: 2030-03-09Ordinary Shares (43,695 underlying)
    43,695
  • Deferred Stock Units

    Ordinary Shares (1,457.167 underlying)
    1,457.167
  • Stock Options (right to buy)

    Exercise: $176.63Exp: 2029-03-20Ordinary Shares (47,020 underlying)
    47,020
  • Ordinary Shares

    (indirect: By 401(k))
    3,052.042
  • Restricted Stock Units

    Ordinary Shares (2,870 underlying)
    2,870
  • Stock Options (right to buy)

    Exercise: $154.00Exp: 2028-02-27Ordinary Shares (64,665 underlying)
    64,665
  • Stock Options (right to buy)

    Exercise: $118.71Exp: 2027-02-28Ordinary Shares (72,795 underlying)
    72,795
  • Restricted Stock Units

    Ordinary Shares (2,625 underlying)
    2,625
  • Stock Options (right to buy)

    Exercise: $354.14Exp: 2033-03-07Ordinary Shares (18,970 underlying)
    18,970
Footnotes (18)
  • [F1]Ordinary shares acquired pursuant to the payout of a restricted stock unit grant made on March 7, 2022.
  • [F10]This option vests over three years in three consecutive equal annual installments beginning on March 7, 2026.
  • [F11]This option vests over three years in three consecutive equal annual installments beginning on March 7, 2025.
  • [F12]This option vests over three years in three consecutive equal annual installments beginning on March 7, 2024.
  • [F13]This option vests over three years in three consecutive equal annual installments beginning on March 7, 2023.
  • [F14]This option vests over three years in three consecutive equal annual installments beginning on March 9, 2021.
  • [F15]This option vested in full and became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant.
  • [F16]This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant.
  • [F17]Conversion to Linde plc Ordinary Shares is on a 1-for-1 basis.
  • [F18]Deferred stock units acquired under the Linde Compensation Deferral Plan ("Plan"). The deferred stock units will payout in Linde plc Ordinary Share on a one-for-one basis in accordance with the Plan.
  • [F2]Ordinary shares withheld from the payout to cover tax withholdings.
  • [F3]Ordinary shares acquired pursuant to the payout of a performance share unit ("PSU") grant made on March 7, 2022.
  • [F4]The PSU paid out on March 10, 2025, and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Linde plc from 2022-2025 measured against ROC goals set by the Human Capital Committee of the Board of Directors when the PSU was granted on March 7, 2022.
  • [F5]The PSU paid out on March 10, 2025, and the number of shares awarded and paid out was determined based upon the total shareholder return ("TSR") of Linde plc from 2022-2025 measured against TSR goals set by the Human Capital Committee of the Board of Directors when the PSU was granted in March 7, 2022.
  • [F6]Restricted Stock Units that will vest in full and payout on or about March 7, 2025 in Linde plc Ordinary Shares on a one-for-one basis.
  • [F7]Restricted Stock Units that will vest in full and payout on or about March 7, 2028 in Linde plc Ordinary Shares on a one-for-one basis.
  • [F8]Restricted Stock Units that will vest in full and payout on or about March 7, 2027 in Linde plc Ordinary Shares on a one-for-one basis.
  • [F9]Restricted Stock Units that will vest in full and payout on or about March 7, 2026 in Linde plc Ordinary Shares on a one-for-one basis.

Issuer

LINDE PLC

CIK 0001707925

Entity typeother

Related Parties

1
  • filerCIK 0001441755

Filing Metadata

Form type
4
Filed
Mar 10, 8:00 PM ET
Accepted
Mar 11, 8:09 PM ET
Size
43.3 KB